Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000898432-23-000624
Filing Date
2023-08-14
Accepted
2023-08-14 16:45:59
Documents
44
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT blac-20230630.htm   iXBRL 10-Q 654704
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARB exh31-1.htm EX-31.1 15546
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARB exh31-2.htm EX-31.2 15539
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARB exh32-1.htm EX-32.1 6767
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARB exh32-2.htm EX-32.2 6931
  Complete submission text file 0000898432-23-000624.txt   3278942

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA blac-20230630.xsd EX-101.SCH 40722
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE blac-20230630_cal.xml EX-101.CAL 15951
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blac-20230630_def.xml EX-101.DEF 177536
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE blac-20230630_lab.xml EX-101.LAB 287539
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blac-20230630_pre.xml EX-101.PRE 184001
38 EXTRACTED XBRL INSTANCE DOCUMENT blac-20230630_htm.xml XML 268198
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41390 | Film No.: 231171436
SIC: 6770 Blank Checks